David Eisel
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- Immunology top 10%
- Psoriasis: Treatment and Pathogenesis
- Immunotherapy and Immune Responses
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune cells in cancer
Papers in
- Immunology 11
- Immunotherapy and Immune Responses 5
- Immune cells in cancer 3
- T-cell and Retrovirus Studies 2
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 1
-
- MicroRNA in disease regulation 2
- Co-authors
- Wolfram Osen (8 shared papers)Stefan B. Eichmüller (8 shared papers)Rainer König (4 shared papers)Elke Dickes (2 shared papers)Holger Heine (1 shared paper)Franziska Herster (1 shared paper)Dominik Hartl (1 shared paper)Nathan K. Archer (1 shared paper)
- Journals
- Cancer Immunology Research (2 papers)Oncotarget (2 papers)Frontiers in Immunology (1 paper)BMC Cancer (1 paper)PLoS ONE (1 paper)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
David Eisel
15 papers receiving 1k citations
David Eisel's Hit Papers
Peers
Comparison fields: 5 of 63
- Infectious Diseases 363
- Immunology 289
- Oncology 75
- Microbiology 21
- Molecular Biology 211
Countries citing papers authored by David Eisel
This map shows the geographic impact of David Eisel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Eisel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Eisel more than expected).
Fields of papers citing papers by David Eisel
This network shows the impact of papers produced by David Eisel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Eisel. The network helps show where David Eisel may publish in the future.
Co-authors
The 25 scholars most cited alongside David Eisel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | BNT162b vaccines protect rhesus macaques from SARS-CoV-2 Hit paper breakdown → | 2021 | 556 |
| 2 | 2020 | 215 | |
| 3 | 2019 | 59 | |
| 4 | 2022 | 51 | |
| 5 | 2020 | 47 | |
| 6 | 2018 | 28 | |
| 7 | 2018 | 23 | |
| 8 | 2017 | 18 | |
| 9 | 2013 | 17 | |
| 10 | 2020 | 12 | |
| 11 | 2024 | 5 | |
| 12 | 2019 | 2 | |
| 13 | 1997 | 1 | |
| 14 | Fre-2, a locus closely linked to Fv-2, is rearranged in some erythroleukemias induced by Friend murine leukemia virus. | 1997 | 1 |
| 15 | 2019 | 1 | |
| 16 | 2026 | 0 |
About David Eisel
David Eisel is a scholar working on Immunology, Cancer Research, Oncology, Hematology and Infectious Diseases, having authored 16 papers that have together received 1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), Immune cells in cancer (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), MicroRNA in disease regulation (2 papers), T-cell and Retrovirus Studies (2 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper), Pancreatic and Hepatic Oncology Research (1 paper) and CRISPR and Genetic Engineering (1 paper). The work is most often cited by research in Infectious Diseases (363 citations), Immunology (289 citations), Oncology (75 citations), Microbiology (21 citations) and Molecular Biology (211 citations). David Eisel has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Wolfram Osen, Stefan B. Eichmüller, Rainer König, Elke Dickes, Holger Heine, Franziska Herster, Dominik Hartl, Nathan K. Archer, Nicole Schneiderhan‐Marra and Tim Vierbuchen. Their work appears in journals such as Cancer Immunology Research, Oncotarget, Frontiers in Immunology, BMC Cancer and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.